DA
GOSS icon

Denali Advisors’s Gossamer Bio GOSS Stock Holding History

Denali Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58
Closed -$9.98K – 460
2022
Q4 		$9.98K Hold
58
– – ﹤0.01% 320
2022
Q3 		$55K Sell
58
-55
-49% -$54.6K 0.03% 201
2022
Q2 		$75K Buy
+113
New +$70K 0.03% 188

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Denali Advisors's GOSS Position: Q1 2023 in Review

Denali Advisors sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 58 shares — an estimated $9.98K sold.

Denali Advisors first reported a position in GOSS in Q2 2022 and held it in 3 quarters. The position peaked at $75K in Q2 2022. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Denali Advisors reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Denali Advisors sold 58 Gossamer Bio shares in Q1 2023, an estimated $9.98K.
  • Denali Advisors first reported a position in Gossamer Bio in Q2 2022 and held it in 3 quarters.
  • Denali Advisors's Gossamer Bio position peaked at $75K in Q2 2022.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Denali Advisors's 13F filing for Q1 2023, filed 21 Apr 2023.